CLIC1 inhibition may have a synergistic effect on tumor cells, as well as tumor vasculature, as our team previously reported for a ccRCC patient-derived tumor xenograft implanted on a chick embryo chorioallantoic membrane treated with anti-CLIC1 antibodies. The gene discussed is CLIC1; the disease is nonpapillary renal cell carcinoma.